Lombard Odier Asset Management (Europe) LTD Charles River Laboratories International, Inc. Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $19,711 - $25,007	-100 Reduced 2.56%	3,800 $827,000
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $796,107 - $1.18 Million	3,900 New	3,900 $834,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1.15 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$956 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$703 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$400 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$364 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account